abstract |
A process for producing a b-nucleoside analogue compound of the formula and salts thereof, wherein R1 is a hydroxyl protecting group; and R2 is a purine or pyrimidine base or an analogue or derivative thereof, the process comprising glycosylating said purine or pyrimidine base at a temperature below about -10oC, with an intermediate of the formula wherein L is halogen. |